106 related articles for article (PubMed ID: 26555707)
1. Pseudomonas aeruginosa pyocyanin modulates mucin glycosylation with sialyl-Lewis(x) to increase binding to airway epithelial cells.
Jeffries JL; Jia J; Choi W; Choe S; Miao J; Xu Y; Powell R; Lin J; Kuang Z; Gaskins HR; Lau GW
Mucosal Immunol; 2016 Jul; 9(4):1039-1050. PubMed ID: 26555707
[TBL] [Abstract][Full Text] [Related]
2. Hyperglycaemia and Pseudomonas aeruginosa acidify cystic fibrosis airway surface liquid by elevating epithelial monocarboxylate transporter 2 dependent lactate-H
Garnett JP; Kalsi KK; Sobotta M; Bearham J; Carr G; Powell J; Brodlie M; Ward C; Tarran R; Baines DL
Sci Rep; 2016 Nov; 6():37955. PubMed ID: 27897253
[TBL] [Abstract][Full Text] [Related]
3. A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms.
Matsui H; Wagner VE; Hill DB; Schwab UE; Rogers TD; Button B; Taylor RM; Superfine R; Rubinstein M; Iglewski BH; Boucher RC
Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18131-6. PubMed ID: 17116883
[TBL] [Abstract][Full Text] [Related]
4. The role of Pseudomonas lipopolysaccharide in cystic fibrosis airway infection.
Moskowitz SM; Ernst RK
Subcell Biochem; 2010; 53():241-53. PubMed ID: 20593270
[TBL] [Abstract][Full Text] [Related]
5. LC-MS/MS determination of pyocyanin-N-acetyl cysteine adduct: application for understanding Pseudomonas aeruginosa virulence factor neutralization.
Farouk F; Shebl RI
Anal Sci; 2024 May; 40(5):891-905. PubMed ID: 38472735
[TBL] [Abstract][Full Text] [Related]
6. Brd4 inhibition ameliorates Pyocyanin-mediated macrophage dysfunction via transcriptional repression of reactive oxygen and nitrogen free radical pathways.
Zhu F; Xiong F; He J; Liu K; You Y; Xu Q; Miao J; Du Y; Zhang L; Ren H; Wang X; Chen J; Li J; Chen S; Liu X; Huang N; Wang Y
Cell Death Dis; 2020 Jun; 11(6):459. PubMed ID: 32541671
[TBL] [Abstract][Full Text] [Related]
7. The Inovirus Pf4 Triggers Antiviral Responses and Disrupts the Proliferation of Airway Basal Epithelial Cells.
Popescu MC; Haddock NL; Burgener EB; Rojas-Hernandez LS; Kaber G; Hargil A; Bollyky PL; Milla CE
Viruses; 2024 Jan; 16(1):. PubMed ID: 38275975
[TBL] [Abstract][Full Text] [Related]
8. Biography of Lewis C. Cantley.
Bradley D
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3327-8. PubMed ID: 14993589
[No Abstract] [Full Text] [Related]
9. Intestinal Current Measurements Detect Activation of Mutant CFTR in Patients with Cystic Fibrosis with the G551D Mutation Treated with Ivacaftor.
Graeber SY; Hug MJ; Sommerburg O; Hirtz S; Hentschel J; Heinzmann A; Dopfer C; Schulz A; Mainz JG; Tümmler B; Mall MA
Am J Respir Crit Care Med; 2015 Nov; 192(10):1252-5. PubMed ID: 26568242
[No Abstract] [Full Text] [Related]
10. Searching for a cure for cystic fibrosis. A 25-year quest in a nutshell.
Bosch B; De Boeck K
Eur J Pediatr; 2016 Jan; 175(1):1-8. PubMed ID: 26567541
[TBL] [Abstract][Full Text] [Related]
11. A Non-Invasive Droplet Digital PCR (ddPCR) Assay to Detect Paternal CFTR Mutations in the Cell-Free Fetal DNA (cffDNA) of Three Pregnancies at Risk of Cystic Fibrosis via Compound Heterozygosity.
Debrand E; Lykoudi A; Bradshaw E; Allen SK
PLoS One; 2015; 10(11):e0142729. PubMed ID: 26561302
[TBL] [Abstract][Full Text] [Related]
12. Novel Hits in the Correction of ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Protein: Synthesis, Pharmacological, and ADME Evaluation of Tetrahydropyrido[4,3-d]pyrimidines for the Potential Treatment of Cystic Fibrosis.
Pesci E; Bettinetti L; Fanti P; Galietta LJ; La Rosa S; Magnoni L; Pedemonte N; Sardone GL; Maccari L
J Med Chem; 2015 Dec; 58(24):9697-711. PubMed ID: 26561003
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis.
Saldanha IJ; Akinyede O; Robinson KA
Cochrane Database Syst Rev; 2015 Nov; (11):CD009421. PubMed ID: 26559561
[TBL] [Abstract][Full Text] [Related]
14. Tobramycin inhalation powder (TOBI Podhaler) for the treatment of lung infection in patients with cystic fibrosis.
Vazquez-Espinosa E; Marcos C; Alonso T; Giron RM; Gomez-Punter RM; Garcia-Castillo E; Zamora E; Cisneros C; Garcia J; Valenzuela C; Ancochea J
Expert Rev Anti Infect Ther; 2016; 14(1):9-17. PubMed ID: 26559549
[TBL] [Abstract][Full Text] [Related]
15. Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin.
Ehsan Z; Clancy JP
Future Microbiol; 2015; 10(12):1901-12. PubMed ID: 26573178
[TBL] [Abstract][Full Text] [Related]
16. Site of Fluid Secretion in Small Airways.
Flores-Delgado G; Lytle C; Quinton PM
Am J Respir Cell Mol Biol; 2016 Mar; 54(3):312-8. PubMed ID: 26562629
[TBL] [Abstract][Full Text] [Related]
17. An LGG-derived protein promotes IgA production through upregulation of APRIL expression in intestinal epithelial cells.
Wang Y; Liu L; Moore DJ; Shen X; Peek RM; Acra SA; Li H; Ren X; Polk DB; Yan F
Mucosal Immunol; 2017 Mar; 10(2):373-384. PubMed ID: 27353252
[TBL] [Abstract][Full Text] [Related]
18. Core 1- and 3-derived O-glycans collectively maintain the colonic mucus barrier and protect against spontaneous colitis in mice.
Bergstrom K; Fu J; Johansson ME; Liu X; Gao N; Wu Q; Song J; McDaniel JM; McGee S; Chen W; Braun J; Hansson GC; Xia L
Mucosal Immunol; 2017 Jan; 10(1):91-103. PubMed ID: 27143302
[TBL] [Abstract][Full Text] [Related]
19. Cross-protective mucosal immunity mediated by memory Th17 cells against Streptococcus pneumoniae lung infection.
Wang Y; Jiang B; Guo Y; Li W; Tian Y; Sonnenberg GF; Weiser JN; Ni X; Shen H
Mucosal Immunol; 2017 Jan; 10(1):250-259. PubMed ID: 27118490
[TBL] [Abstract][Full Text] [Related]
20. Neonatal colonization of mice with LGG promotes intestinal development and decreases susceptibility to colitis in adulthood.
Yan F; Liu L; Cao H; Moore DJ; Washington MK; Wang B; Peek RM; Acra SA; Polk DB
Mucosal Immunol; 2017 Jan; 10(1):117-127. PubMed ID: 27095077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
